On Monday, LENZ Therapeutics Inc (NASDAQ: LENZ) was -5.40% drop from the session before, before settling in for the closing price of $48.74. A 52-week range for LENZ has been $16.53 – $50.40.
Healthcare Sector giant saw their annual sales slid by -181.63% over the last five years. When this article was written, the company’s average yearly earnings per share was at -11.08%. With a float of $24.40 million, this company’s outstanding shares have now reached $28.50 million.
LENZ Therapeutics Inc (LENZ) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward LENZ Therapeutics Inc stocks. The insider ownership of LENZ Therapeutics Inc is 15.24%, while institutional ownership is 92.21%. The most recent insider transaction that took place on Sep 30 ’25, was worth 6,117,323. In this transaction 10% Owner of this company sold 132,944 shares at a rate of $46.01, taking the stock ownership to the 1,050,599 shares. Before that another transaction happened on Sep 30 ’25, when Company’s 10% Owner sold 92,030 for $46.01, making the entire transaction worth $4,234,695. This insider now owns 764,127 shares in total.
LENZ Therapeutics Inc (LENZ) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.38 earnings per share (EPS) during the time that was better than consensus figure (set at -0.43) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 52.23% during the next five years compared to -181.63% drop over the previous five years of trading.
LENZ Therapeutics Inc (NASDAQ: LENZ) Trading Performance Indicators
You can see what LENZ Therapeutics Inc (LENZ) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 20.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 263.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.90, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -2.54 in one year’s time.
Technical Analysis of LENZ Therapeutics Inc (LENZ)
Analysing the last 5-days average volume posted by the [LENZ Therapeutics Inc, LENZ], we can find that recorded value of 0.6 million was better than the volume posted last year of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 75.42%.
During the past 100 days, LENZ Therapeutics Inc’s (LENZ) raw stochastic average was set at 82.50%, which indicates a significant increase from 60.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.34 in the past 14 days, which was higher than the 2.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.02, while its 200-day Moving Average is $30.10. Now, the first resistance to watch is $48.43. This is followed by the second major resistance level at $50.75. The third major resistance level sits at $52.28. If the price goes on to break the first support level at $44.59, it is likely to go to the next support level at $43.06. Now, if the price goes above the second support level, the third support stands at $40.74.
LENZ Therapeutics Inc (NASDAQ: LENZ) Key Stats
There are 28,522K outstanding shares of the company, which has a market capitalization of 1.32 billion. As of now, sales total 0 K while income totals -49,770 K. Its latest quarter income was 5,000 K while its last quarter net income were -14,910 K.
